Eupraxia Pharmaceuticals Inc.
(EPRX - NASDAQ)
6,87 USD
📋 Profilo Aziendale

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

|